The application of polyhydroxyalkanoates as tissue engineering materials

Doi, 2002 Chen, 2000, Microbial production of biopolyesters-polyhydroxyalkanoates, Prog Nat Sci, 10, 843 Hrabak, 1992, 1ndustrial production of poly β-hydroxybutyrate, FEMS Microbiol Rev, 103, 251 Byrom, 1992, Production of poly β-hydroxybutyrate and poly β-hydroxyvalerate copolymers, FEMS Microbiol Rev, 103, 247 Williams SF, Martin DP, Skraly FA. Medical devices and applications of polyhydroxyalkanoate polymers. US Patent Appl 535146, 2000. Chen, 2001, Industrial Production of Poly(hydroxybutyrate-co-hydroxyhexanoate), Appl Microbiol Biotechnol, 57, 50, 10.1007/s002530100755 Doi, 1995, Microbial synthesis and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate), Macromolecules, 28, 4822, 10.1021/ma00118a007 Williams SF, Martin. Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate. US Patent Appl 661948, 2000. Reusch, 1995, Low molecular weight complexed poly(3-hydroxybutyrate): a dynamic and versatile molecule in vivo, Can J Microbiol, 41, 50, 10.1139/m95-167 Martin DP, Peoples OP, Williams SF, Zhong LH. Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers. US Patent Appl 359086, 1999. Williams SF, Martin DP, Gerngross T, Horowitz DM. Medical device containing polyhydroxyalkanoate treated with oxidizing agent to remove endotoxin. US Patent Appl 819447, 2001. Sevastianov, 2003, Production of purified polyhydroxyalkanoates (PHAs) for applications in contact with blood, J Biomater Sci Polym Ed, 14, 1029, 10.1163/156856203769231547 Nebe, 2001, Structural alterations of adhesion mediating components in cells cultured on poly β-hydroxy butyric acid, Biomaterials, 22, 2425, 10.1016/S0142-9612(00)00430-0 Shishatskaya, 2004, A comparative investigation of biodegradable polyhydroxyalkanoate films as matrices for in vitro cell cultures, J Mater Sci-Mater M, 15, 915, 10.1023/B:JMSM.0000036280.98763.c1 Tezcaner, 2003, Retinal pigment epithelium cell culture on surface modified poly(hydroxybutyrate-co-hydroxyvalerate) thin films, Biomaterials, 24, 4573, 10.1016/S0142-9612(03)00302-8 Doyle, 1991, In vitro and in vivo evaluation of polyhydroxybutyrate and of polyhydroxybutyrate reinforced with hydroxyapatite, Biomaterials, 12, 841, 10.1016/0142-9612(91)90072-I Ni, 2002, In vitro evaluation of hydroxyapatite reinforced polyhydroxybutyrate composite, Mater Sci Eng C-Bio S, 20, 101, 10.1016/S0928-4931(02)00019-X Luklinska, 1997, Morphology and ultrastructure of the interface between hydroxyapatite-polyhydroxybutyrate composite implant and bone, J Mater Sci-Mater M, 8, 379, 10.1023/A:1018589018205 Chen, 2002, Production and evaluation of biodegradable composites based on PHB–PHV copolymer, Biomaterials, 23, 2631, 10.1016/S0142-9612(01)00394-5 Galego, 2000, Characterization and application of poly(β-hydroxyalkanoates) family as composite biomaterials, Polym Test, 19, 485, 10.1016/S0142-9418(99)00011-2 Luklinska, 2003, In vivo response to HA-polyhydroxybutyrate/polyhydroxyvalerate composite, J Microsc-Oxford, 211, 121, 10.1046/j.1365-2818.2003.01204.x Zheng, 2003, Chemical reaction of PHBV/sol–gel bioglass foams for born tissue engineering in simulated body fluid, Chem J Chin U, 24, 1325 Köse, 2004, In vivo tissue engineering of bone using poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid) and collagen scaffolds, Tissue Eng, 10, 1234, 10.1089/ten.2004.10.1234 Al-Salihi, 2004, Coral-polyhydroxybutrate composite scaffold for tissue engineering: prefabrication properties, Med J Malaysia, 59, 202 Shamsuria, 2004, In vitro cytotoxicity evaluation of biomaterials on human osteoblast cells CRL-1543; hydroxyapatite, natural coral and polyhydroxybutarate, Med J Malaysia, 59, 174 Köse, 2003, Bone generation on PHBV matrices: an in vitro study, Biomaterials, 24, 4999, 10.1016/S0142-9612(03)00417-4 Köse, 2003, Poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid) based tissue engineering matrices, J Mater Sci-Mater M, 14, 121, 10.1023/A:1022063628099 Knowles, 1992, Development of a degradable composite for orthopaedic use: in vivo biomechanical and histological evaluation of two bioactive degradable composites based on the polyhydroxybutyrate polymer, Biomaterials, 13, 491, 10.1016/0142-9612(92)90099-A Tesema, 2004, Bone cell viability on collagen immobilized poly (3-hydroxybutrate-co-3-hydroxyvalerate) membrane: effect of surface chemistry, J Appl Polym Sci, 93, 2445, 10.1002/app.20787 Chen, 2003, Surface modification of polyhydroxyalkanoates by ion implantation. Characterization and cytocompatibility improvement, Polym J, 35, 148, 10.1295/polymj.35.148 Wu, 2004, Biocompatibility of modified poly beta-hydroxybutyric acid to adrenocortical cells, J Wuhan Univ Tech-Mater Sci Ed, 19, 38, 10.1007/BF03000164 Lee, 2004, Nanofabrication of microbial polyester by electrospinning promotes cell attachment, Macromol Res, 12, 374, 10.1007/BF03218414 Hu, 2004, Biocompatibility and antibacterial activity of chitosan and collagen immobilized poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid), Carbohyd Polym, 58, 173, 10.1016/j.carbpol.2004.06.039 Hu, 2003, Protein adsorption, fibroblast activity and antibacterial properties of poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid) grafted with chitosan and chitooligosaccharide after immobilized with hyaluronic acid, Biomaterials, 24, 2685, 10.1016/S0142-9612(03)00079-6 Santos, 2004, Differentiation pattern of Vero cells cultured on poly(l-lactic acid)/poly(hydroxybutyrate-co-hydroxyvalerate) blends, Artif Organs, 28, 381, 10.1111/j.1525-1594.2004.47199.x Cheng, 2003, Biocompatibility and biodegradability of poly(hydroxybutyrate)/poly(ethylene glycol) films, J Mater Sci-Mater M, 14, 1073, 10.1023/B:JMSM.0000004004.37103.f4 Shishatskaya, 2004, Tissue response to the implantation of biodegradable polyhydroxyalkanoate sutures, J Mater Sci-Mater M, 15, 719, 10.1023/B:JMSM.0000030215.49991.0d Volova, 2003, Results of biomedical investigations of PHB and PHB/PHV fibers, Biochem Eng J, 16, 125, 10.1016/S1369-703X(03)00038-X Mosahebi, 2002, Effect of allogeneic Schwann cell transplantation on peripheral nerve regeneration, Exp Neurol, 173, 213, 10.1006/exnr.2001.7846 Borkenhagen, 1998, In vivo performance of a new biodegradable polyester urethane system used as a nerve guidance channel, Biomaterials, 19, 2155, 10.1016/S0142-9612(98)00122-7 Novikov, 2002, A novel biodegradable implant for neuronal rescue and regeneration after spinal cord injury, Biomaterials, 23, 3369, 10.1016/S0142-9612(02)00037-6 Unverdorben, 2002, A polyhydroxybutyrate biodegradable stent: preliminary experience in the rabbit, Cardiovasc Intervent Radiol, 25, 127, 10.1007/s00270-001-0118-3 Löbler, 2003, Biomaterial implants induce the inflammation marker CRP at the site of implantation, J Biomed Mater Res, 61, 165, 10.1002/jbm.10155 Gotfredsen, 1994, Immediate implant placement using a biodegradable barrier, polyhydroxybutyrate-hydroxyvalerate reinforced with polyglactin 910. An experimental study in dogs, Clin Oral Implan Res, 5, 83, 10.1034/j.1600-0501.1994.050204.x Leenstra, 1998, The healing process of palatal tissues after palatal surgery with and without implantation of membranes: an experimental study in dogs, J Mater Sci-Mater M, 9, 249, 10.1023/A:1008848509911 Malm, 1994, Enlargement of the right-ventricular outflow tract and the pulmonary-artery with a new biodegradable patch in transannular position, Eur Surg Res, 26, 298, 10.1159/000129349 Martin, 2003, Medical applications of poly 4-hydroxybutyrate: a strong flexible absorbable biomaterial, Biochem Eng J, 16, 97, 10.1016/S1369-703X(03)00040-8 Engelmayr, 2003, A novel bioreactor for the dynamic flexural stimulation of tissue engineered heart valve biomaterials, Biomaterials, 24, 2523, 10.1016/S0142-9612(03)00051-6 Opitz, 2004, Tissue engineering of aortic tissue: dire consequence of suboptimal elastic fiber synthesis in vivo, Cardiovasc Res, 63, 719, 10.1016/j.cardiores.2004.05.002 Opitz, 2004, Tissue engineering of ovine aortic blood vessel substitutes using applied shear stress and enzymatically derived vascular smooth muscle cells, Ann Biomed Eng, 32, 212, 10.1023/B:ABME.0000012741.85600.f1 Sodian, 2002, Application of stereolithography for scaffold fabrication for tissue engineered heart valves, ASAIO J, 48, 12, 10.1097/00002480-200201000-00004 Sodian, 2000, Early in vivo experience with tissue-engineered trileaflet heart valves, Circulation, 102, 22 Sodian, 2000, Tissue engineering of heart valves: in vitro experiences, Ann Thorac Surg, 70, 140, 10.1016/S0003-4975(00)01255-8 Sodian, 2000, Evaluation of biodegradable, three-dimensional matrices for tissue engineering of heart valves, ASAIO J, 46, 107, 10.1097/00002480-200001000-00025 Sodian, 2000, Fabrication of a trileaflet heart valve scaffold from a polyhydroxyalkanoate biopolyester for use in tissue engineering, Tissue Eng, 6, 183, 10.1089/107632700320793 Stock, 2000, Tissue-engineered valved conduits in the pulmonary circulation, J Thorac Cardiovasc Surg, 119, 732, 10.1016/S0022-5223(00)70008-0 Perry, 2003, Thoracic surgery directors association award. Bone marrow as a cell source for tissue engineering heart valves, Ann Thorac Surg, 75, 761, 10.1016/S0003-4975(02)03776-1 Fu, 2004, Effects of basic fibroblast growth factor and transforming growth factor-beta on maturation of human pediatric aortic cell culture for tissue engineering of cardiovascular structures, ASAIO J, 50, 9, 10.1097/01.MAT.0000104815.21056.08 Fuchs, 2003, Fetal tissue engineering: in vitro analysis of muscle constructs, J Pediatr Surg, 38, 1348, 10.1016/S0022-3468(03)00394-4 Dvorin, 2003, Quantitative evaluation of endothelial progenitors and cardiac valve endothelial cells: proliferation and differentiation on poly glycolic acid/poly 4-hydroxybutyrate scaffold in response to vascular endothelial growth factor and transforming growth factor beta1, Tissue Eng, 9, 487, 10.1089/107632703322066660 Yang, 2002, Effect of surface treatment on the biocompatibility of microbial polyhydroxyalkanoates, Biomaterials, 23, 1391, 10.1016/S0142-9612(01)00260-5 Zhao, 2002, Effect of lipase treatment on the biocompatibility of microbial polyhydroxyalkanoates, J Mater Sci-Mater M, 13, 849, 10.1023/A:1016596228316 Zhang, 2000, Wettability improvement of bacterial polyhydroxyalkanoates via ion implantation, Surf Coat Tech, 131, 350, 10.1016/S0257-8972(00)00810-0 Wang, 2003, Reduced mouse fibroblast cell growth by increased hydrophilicity of microbial polyhydroxyalkanoates via hyaluronan coating, Biomaterials, 24, 4621, 10.1016/S0142-9612(03)00356-9 Zhao, 2003, Polyhydroxyalkanoate (PHA) scaffolds with good mechanical properties and biocompatibility, Biomaterials, 24, 1041, 10.1016/S0142-9612(02)00426-X Zhao, 2003, Effects of surface morphology on the biocompatibility of polyhydroxyalkanoates, Biochem Eng J, 16, 115, 10.1016/S1369-703X(03)00029-9 Wang, 2004, Attachment, proliferation and differentiation of osteoblasts on random biopolyester poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) scaffolds, Biomaterials, 25, 669, 10.1016/S0142-9612(03)00561-1 Wang, 2005, Evaluation of three-dimensional scaffolds made of blends of hydroxyapatite and poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) for bone reconstruction, Biomaterials, 26, 899, 10.1016/j.biomaterials.2004.03.035 Yang, 2004, Studies on bone marrow stromal cells affinity of poly (3-hydroxybutyrate-co-3-hydroxyhexanoate), Biomaterials, 25, 1365, 10.1016/j.biomaterials.2003.08.018 Wang, 2005, Effect of composition of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) on growth of fibroblast and osteoblast, Biomaterials, 26, 755, 10.1016/j.biomaterials.2004.03.023 Deng, 2002, Study on the three-dimensional proliferation of rabbit articular cartilage-derived chondrocytes on polyhydroxyalkanoate scaffolds, Biomaterials, 23, 4049, 10.1016/S0142-9612(02)00136-9 Deng, 2003, Poly(hydroxybutyrate-co-hydroxyhexanoate) promoted production of extracellular matrix of articular cartilage chondrocytes in vitro, Biomaterials, 24, 4273, 10.1016/S0142-9612(03)00367-3 Martin DP, Skraly F, Williams SF. Polyhydroxyalkanoate compositions having controlled degradation rates. US Patent Appl 403242, 2003. Gursel, 2002, In vitro antibiotic release from poly(3-hydroxybutyrate-co-3-hydroxyvalerate) rods, J Microencapsul, 19, 153, 10.1080/02652040110065413 Turesin, 2001, Biodegradable polyhydroxyalkanoate implants for osteomyelitis therapy: in vitro antibiotic release, J Biomater Sci Polym Ed, 12, 195, 10.1163/156856201750180924 Khang, 2001, Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres for the sustained release of 5-fluorouracil, Biomed Mater Eng, 11, 89 Pouton, 1996, Biosynthetic polyhydroxyalkanoates and their potential in drug delivery, Adv Drug Deliver Rev, 18, 133, 10.1016/0169-409X(95)00092-L Yagmurlu, 1999, Sulbactam-cefoperazone polyhydroxybutyrate-co-hydroxyvalerate (PHBV) local antibiotic delivery system: In vivo effectiveness and biocompatibility in the treatment of implant-related experimental osteomyelitis, J Biomed Mater Res, 46, 494, 10.1002/(SICI)1097-4636(19990915)46:4<494::AID-JBM7>3.0.CO;2-E Sendil, 1999, Antibiotic release from biodegradable PHBV microparticles, J Control Release, 59, 207, 10.1016/S0168-3659(98)00195-3 Miller, 1987, On the biodegradation of poly beta-hydroxybutyrate homopolymer and poly beta-hydroxybutyrate-hydroxyvalerate copolymers, Biomaterials, 8, 129, 10.1016/0142-9612(87)90102-5 Freier, 2002, In vitro and in vivo degradation studies for development of a biodegradable patch based on poly(3-hydroxybutyrate), Biomaterials, 23, 2649, 10.1016/S0142-9612(01)00405-7 Wang, 2004, Biodegradation studies of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate), Polym Degrad Stabil, 85, 815, 10.1016/j.polymdegradstab.2004.02.010 Williams, 1999, PHA applications: addressing the price performance issue I. Tissue engineering, Int J Biol Macromol, 25, 111, 10.1016/S0141-8130(99)00022-7